Eargo receives notification from nasdaq related to delayed quarterly report on form 10-q

San jose, calif., nov. 22, 2021 (globe newswire) -- eargo, inc. (nasdaq: ear) (the “company” or “eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the company received a letter from the nasdaq stock market llc (“nasdaq”) indicating that, since the company has not yet filed its quarterly report on form 10-q for the period ended september 30, 2021 (the “form 10-q”), the company no longer complies with nasdaq listing rule 5250(c)(1) for continued listing.
EAR Ratings Summary
EAR Quant Ranking